It is worth mentioning that the immunotherapy, especially the targeting PD‐1/PD‐L1, has achieved marked success in multiple human cancers,48, 49 and it also has a potential clinical value in the treatment of gliomas. The gene discussed is CD274; the disease is central nervous system cancer.